Anish Patel, CHIEF OPERATING OFFICER at Enliven Therapeutics, Inc. (ELVN), sold 11,621 shares at $20.76 ($243K) on 2025-12-08, disclosed to the SEC on 2025-12-10.
Scheduled sale ($243k) by CHIEF OPERATING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.76 | 4,958 | $103K | 42.4% |
| 2 | $20.76 | 4,958 | $103K | 42.4% |
| 3 | $21.78 | 1,705 | $37K | 15.3% |
| Total | $20.91 avg | 11,621 | $243K | 100% |
| Filing → |
| ELVN | SELL | 2025-10-09 | $268K | — | Filing → |
| ELVN | SELL | 2025-09-10 | $270K | — | Filing → |
| ELVN | SELL | 2025-08-11 | $236K | — | Filing → |